Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
Randall Paul
Oct 12, 2022 3:25PM ET
BS Corporate manipulation for profit stop
0
0
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
Free Webinar - Webinar: Simplify Options Trading | Thursday, September 28, 2023 | 08:00PM EDT Enroll Now
U.S. authorizes updated COVID booster shots for children as young as 5
Published Oct 12, 2022 09:58AM ET
Updated Oct 12, 2022 02:15PM ET
(Reuters) -U.S. health regulators authorized the use of Omicron-tailored COVID-19 booster shots from Moderna (NASDAQ:MRNA) Inc and Pfizer Inc (NYSE:PFE) in children as young as 5, a move that will expand the government's fall vaccination campaign.
The U.S. Food and Drug Administration on Wednesday green-lighted Moderna's bivalent vaccine for those aged six and above, while Pfizer's updated shot was authorized in children aged five and above.
The U.S. Centers for Disease Control and Prevention also backed the FDA's authorization, clearing the way for the shots to be administered in children.
The redesigned bivalent booster shots from both Moderna and Pfizer target the original version as well as the BA.4 and the currently dominant BA.5 subvariants of Omicron.
"Since children have gone back to school in person and people are resuming pre-pandemic behaviors and activities, there is the potential for increased risk of exposure to the virus," said Peter Marks, head of FDA's Center for Biologics Evaluation and Research.
Overall, COVID-19 vaccination rates in the United States have stayed low among kids, with nearly 40% of children aged 5-11 vaccinated with one dose of a vaccine so far.
Pfizer/BioNTech's vaccine will be shipped immediately after the CDC's recommendation, the companies said.
Pfizer said it has the capacity to ship up to 6 million pediatric doses in the first seven calendar days, without any impact to distribution output of the doses for individuals aged 12 years and older.
The BA.5 subvariant of Omicron currently remains the dominant strain, accounting for nearly 79% of the cases in the United States.
Around 11.5 million people received the updated shots over the first five weeks of the rollout last month, which represents just 5.4% of the people aged 12 or older who are eligible to receive them.
Related Articles
Comments (5)
Butch Einsel
Oct 12, 2022 2:30PM ET
my personal doctor told me it's the biggest scam in history
3
0
Art Carrano
Oct 12, 2022 1:59PM ET
Yeah no.
0
0
gene morris
Oct 12, 2022 10:42AM ET
these vaccines have become IQ tests for parents.
5
0
Brad Albright
Oct 12, 2022 10:09AM ET
Qnuts in 3, 2, 1...
0
3
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.